Newborn screening by tandem mass spectrometry (MS-MS)

Newborn screening for selected inherited metabolic disorders is a well-established public health measure in most developed countries [1/. The purpose is to identify and properly diagnose individuals in the neonatal period to enable early medical intervention to prevent or significantly reduce clinical symptoms such as mental retardation. Some of the basic criteria for determining which inherited disorders are suitable for newborn